Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II

NCT01816555 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT01816555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01816555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II
Lead sponsor
Medical University of South Carolina
Phase
Phase 1
Overall status
Terminated
Start date
January 31, 2013
Completion date
November 30, 2014
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

newly diagnosed operative invasive ductal breast carcinoma stage i-ii